194032-17-2 Usage
Uses
Used in Organic Synthesis:
4-METHYL-5-NITROISOQUINOLINE is used as a synthetic building block for the creation of more complex organic molecules. Its unique structure and functional groups make it a valuable intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-METHYL-5-NITROISOQUINOLINE is used as a key intermediate in the development of new drugs. Its chemical properties allow for the formation of diverse molecular structures, which can be tailored to target specific biological pathways or receptors, potentially leading to the discovery of novel therapeutic agents.
Used in Research and Development:
4-METHYL-5-NITROISOQUINOLINE is also utilized in academic and industrial research settings as a tool to study the properties and reactivity of isoquinoline-based compounds. This can help researchers gain insights into the design and synthesis of new molecules with potential applications in various fields, including medicine, materials science, and chemical engineering.
Check Digit Verification of cas no
The CAS Registry Mumber 194032-17-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,0,3 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 194032-17:
(8*1)+(7*9)+(6*4)+(5*0)+(4*3)+(3*2)+(2*1)+(1*7)=122
122 % 10 = 2
So 194032-17-2 is a valid CAS Registry Number.
194032-17-2Relevant articles and documents
ROCK KINASE INHIBITORS
-
Paragraph 0201-0202; 0204; 0273-0276; 0278, (2020/05/29)
The present invention relates to compounds that inhibit ROCK activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of inhibiting ROCK activity and methods for treating, for example cerebral cavernous malformation syndrome (CCM) and cardiovascular diseases using the compounds and pharmaceutical compositions of the present invention.
ISOQUINOLINESULFONAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
-
, (2008/06/13)
This invention relates to isoquinolinesulfonamide derivatives represented by the following formula (1): wherein A represents a linear or branched alkylene group, R1 represents a hydrogen atom, an hydroxyl, alkoxy or alkyl group or the like, R2 represents a hydrogen atom, an alkyl group or the like, R3 represents a hydrogen atom, an alkyl group or the like, and R4 and R5 may be the same or different and individually represent hydrogen atoms or lower alkyl groups; N-oxides and salts thereof; and solvates thereof. This invention is also concerned with pharmaceutical compositions, which contain the derivatives, N-oxides, salts, or solvates. These derivatives, N-oxides, salts, and solvates have viral proliferation inhibiting activities and are useful as AIDS therapeutics.
